Stay updated on SAR444245 and Cemiplimab in Skin Cancers Clinical Trial
Sign up to get notified when there's something new on the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page.

Latest updates to the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe site footer revision changes from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check26 days agoChange DetectedThe study record now includes a References section, and a sitewide NIH notice describes the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference0.6%

- Check33 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check40 days agoChange DetectedThe site’s footer revision identifier changes from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check61 days agoChange DetectedThe study record history now includes the added 'Revision: v3.7.0' and the removed 'Revision: v3.6.6'. This indicates the record has been updated to a newer version.SummaryDifference0.1%

- Check82 days agoChange DetectedA new revision entry labeled v3.6.6 was added to the study's record history, signaling a recent sponsor update. The previous revision, v3.6.5, was removed from the visible history.SummaryDifference0.1%

Stay in the know with updates to SAR444245 and Cemiplimab in Skin Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page.